Advances in Antibody-Based Immunotherapy in Multiple Myeloma
Time: 9:30 am
day: Day One
Details:
- Myeloma is still not curable
- Novel immunotherapies will improve patient outcome
- Off-the-shelf bispecific antibodies are ideally suited for wide spread clinical applications
